Benzodiazepine discontinuation and patient outcomes

Join L. Joseph Parker, a research physician, as we explore a recent comparative effectiveness study that investigates the impact of discontinuing long-term benzodiazepine therapy on patients' mortality and adverse events, especially when considering their baseline opioid exposure. Discover the key findings, implications, and the potential risks and benefits associated with benzodiazepine discontinuation in patients prescribed for stable long-term treatment. L. Joseph Parker is a research physician. He discusses the KevinMD article, "Redefining medical caution: How recent studies challenge benzodiazepine prescription norms." Our presenting sponsor is Nuance, a Microsoft company. Do you spend more time on administrative tasks like clinical documentation than you do with patients? You're not alone. Clinicians report spending up to two hours on administrative tasks for each hour of care provided. Nuance, a Microsoft company, is committed to helping clinicians restore the balance with Dragon Ambient eXperience – or DAX for short. DAX is an AI-powered, voice-enabled solution that helps physicians cut documentation time in half. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. DAX Copilot can be easily enabled within the workflow of the Dragon Medical application to bring the power of ambient technology to more clinicians faster while leveraging the proven and powerful capabilities used by over 550,000 physicians. Explore DAX Copilot today. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. Discover clinical documentation that writes itself and reclaim your work-life balance. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/gImuWR Powered by CMEfy.